Navigation Links
Merriman Curhan Ford Acted as Placement Agent in GenVec's $28 Million Registered Offering
Date:2/1/2010

been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal cancer, and head and neck cancer. In addition, GenVec uses its proprietary  adenovector technology  to develop vaccines for infectious diseases including influenza, HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), and HSV-2. GenVec also discovers and develops novel treatments for hearing loss and balance disorders through a worldwide collaboration with Novartis. Additional information about GenVec is available at www.genvec.com and in the company's various filings with the Securities and Exchange Commission.

About Merriman Curhan Ford

Merriman Curhan Ford (NASDAQ: MERR) is a financial services firm focused on fast-growing companies and the institutions that invest in them. The company offers high-quality investment banking, equity research, institutional services and corporate & venture services, and specializes in five growth industry sectors: CleanTech, Consumer, Media & Internet, Health Care, Natural Resources and Technology.  For more information, please go to www.mcfco.com.

Note'/>"/>

SOURCE Merriman Curhan Ford
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Merriman Curhan Ford Acted as Lead Placement Agent in PolyMedixs $20.7 Million Equity Financing
2. Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th
3. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
4. ProMetic to present at Merriman Curhan Fords Investor Summit 2008 on September 16th
5. Bionovo to Present at Merriman Curhan Fords Investor Summit 2008 on September 15th
6. SuperGen to Present at Merriman 5th Annual Investor Summit on September 15, 2008
7. Solta Medical to Raise $17.2 Million in Private Placement
8. KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals
9. Encorium Group, Inc. Completes $1.6 Million Private Placement of Common Stock and Executes Warrant Exchange Agreement; Ends Discussions to Sell Encorium OY
10. Helix BioPharma Closes Private Placement
11. Building better bone replacements with bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 OTC Markets ... Inc., a biotechnology company, on its approval to ... traded on OTCQX®, the best marketplace for established ... Group. Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ... successful execution of its growth strategy and achievement ...
(Date:8/21/2014)... 21, 2014 Pursuit Solutions ( ... technology and services for Life Sciences sales and ... Use of New Commercial Sales Models” by Peter ... , The article examines some innovative models used ... being tested in the pharmaceutical market. Robinson grades ...
(Date:8/21/2014)... 21, 2014 SoundConnect , ... recognized as one of the nation’s Fastest Growing ... for the 2nd consecutive year. Inc. magazine today ... Inc. 500|5000, an exclusive ranking of the nation's ... comprehensive look at the most important segment of ...
(Date:8/20/2014)... to biotechnology firms has revealed early bottlenecks on ... the researchers suggest that better communication of basic ... to faster commercialization down the road. , Biopharmaceutical ... university laboratories and licensed to biotechnology firms. Bottlenecks ... a high failure rate. But a new study ...
Breaking Biology Technology:OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3
... SAN DIEGO, Feb. 27 Anadys Pharmaceuticals,Inc. (Nasdaq: ... the Susquehanna,Second Annual SIGnificant Options in Healthcare Conference on ... PST). The conference is being,held at the W Hotel ... Chief Executive Officer of Anadys,Pharmaceuticals, Inc., will present an ...
... researchers at North Carolina State University have demonstrated ... or chemically different so-called Janus particles ... electrical field is applied to liquid surrounding the ... in the Feb. 8, 2008, edition of Physical ...
... of Stock Repurchase Program -, LIONVILLE, Pa., Feb. 27 ... that its Board of Directors,approved a second quarter 2008 cash ... May 7, 2008 to shareholders of record on April 23,2008., ... shares of,its common stock at an average price of $40.23 ...
Cached Biology Technology:Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference 2'2-faced' particles act like tiny submarines 2
(Date:8/22/2014)... 21, 2014 Diabetes affects nearly 10 percent ... of diabetics: constant finger pricking to test blood ... Biology reports the development of a protein that ... results for diabetes patients. In the American Chemical ... Ph.D., shows off her "designer protein" that could ...
(Date:8/22/2014)... release is available in German . ... substances, in PCFs proteins are fixated in a way ... crystals. Next, the HZB and Fudan University researchers are ... as functional materials. Their findings are being published today ... 10.1038/ncomms5634). , Proteins are sensitive molecules. Everyone knows that ...
(Date:8/22/2014)... In 2015, American consumers will finally be able to ... Although touted as zero-emissions vehicles, most of the cars ... fossil fuel that contributes to global warming. , Now ... device that uses an ordinary AAA battery to produce ... electric current through two electrodes that split liquid water ...
Breaking Biology News(10 mins):Proteins: New class of materials discovered 2Stanford scientists develop a water splitter that runs on an ordinary AAA battery 2Stanford scientists develop a water splitter that runs on an ordinary AAA battery 3
... have created an application that enables cell phones and ... English speakers and could be used for people who ... type in the menu listing and the application translates ... "Mimi" Boutin, an associate professor in Purdue University,s School ...
... Belmont, MAA new study from McLean Hospital/Harvard Medical ... genetic research drawing correlations between specific genes, environmental ... the development of some psychiatric illnesses needs additional ... , McLean Hospital investigator Laramie Duncan, PhD, ...
... faster than ever and not only when it ... bodies are reaching puberty at an increasingly earlier age, ... adult lives. That,s bad news, according to Tel Aviv ... Hyperostosis Frontalis Interna (HFI), a hormonal condition once typically ...
Cached Biology News:New translator app makes sense of foreign-language food menus 2New translator app makes sense of foreign-language food menus 3McLean: Improvements are needed for accuracy in gene-by-environment interaction studies 2McLean: Improvements are needed for accuracy in gene-by-environment interaction studies 3Is estrogen going to your head? 2Is estrogen going to your head? 3
... HT is designed for extended ... HT is ideal for applications ... primer extension assays. iEMS Incubator/Shaker ... one-cabinet model, allowing the capacity ...
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. It can incubate up to ...
... Anti-Reverse Cap Analog (ARCA) is a modified ... group (closer to m7G) is replaced with ... polymerase can only initiate transcription with the ... in the forward orientation. As a result, ...
Biology Products: